The $15bn ‘viral’ AI start-up changing how American doctors treat patients
Source: Financial Times (AI) (opens in a new tab)
Intel Summary
The Financial Times reports that AI startup OpenEvidence has reached a $15 billion valuation. According to the company's founder, two-thirds of US physicians now use its ad-supported medical chatbot, raising scrutiny and debate surrounding its influence on clinical workflows and patient care.
Why It Matters
Rapid adoption of commercial, ad-funded AI tools in clinical settings introduces significant governance, liability, and conflict-of-interest questions for healthcare organizations. Health systems and regulators must evaluate whether ad-driven incentives compromise diagnostic recommendations and patient treatment decisions.
Organizations & Entities
- America
Related Intelligence
- ReportAlso involving America
U.S. bans DeepSeek from government agency systems amid AI rift with China
CNBC reports that the U.S. Department of Homeland Security has banned DeepSeek-related technology across federal civilian agency IT systems amid escalating artificial intelligence tensions between the United States and China.
CNBC Tech - ReportAlso involving America
US bans Deepseek technology across federal civilian agencies
The Decoder reports that the US Department of Homeland Security has prohibited federal civilian agencies from using artificial intelligence technology developed by Chinese lab DeepSeek. The report does not detail specific enforcement mechanisms or implementation deadlines.
The Decoder - DevelopmentNewAlso involving America
OpenEvidence reaches $15 billion valuation
The Financial Times reports that AI startup OpenEvidence has reached a $15 billion valuation. Claims are as reported; this summary makes no determination about accuracy or significance.
- DevelopmentNewAlso involving America
AI deepfakes appear in US political attack ads
The Financial Times reports that AI-generated deepfakes and manipulated images are increasingly appearing in broadcast political attack ads across the United States ahead of the upcoming November midterm elections. Claims are as reported; this summary makes no determination about accuracy or significance.